Cholangiopathy and Tumors of the Pancreas, Liver, and Biliary Tree in Boys with X-Linked Immunodeficiency with Hyper-IgM

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 977-983

  Hayward, Anthony R ^a,g   Levy, Jacov ^b   Facchetti, Fabio ^c   Notarangelo, Luigi ^c   Ochs, Hans D ^d   Etzioni, Amos ^e   Bonnefoy, Jean Yves ^f   Cosyns, Mary ^a   Weinberg, Adriana ^a  

^a Children's Hospital Colorado   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e RAMBAM MEDICAL CENTER   (Israel)

^f GLAXO INST FOR MOLECULAR BIOLOGY   (Switzerland)

^g UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; BILIARY TRACT DISEASE; BILIARY TRACT TUMOR; CHILD; CRYPTOSPORIDIOSIS; CYTOMEGALIC INCLUSION BODY DISEASE; GENETICS; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; IMMUNOLOGY; LIVER TUMOR; MALE; PANCREAS TUMOR; PATHOLOGY; X CHROMOSOME;

ADOLESCENT; ADULT; BILIARY TRACT DISEASES; BILIARY TRACT NEOPLASMS; CHILD; CRYPTOSPORIDIOSIS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN M; IMMUNOLOGIC DEFICIENCY SYNDROMES; LIVER NEOPLASMS; MALE; PANCREATIC NEOPLASMS; X CHROMOSOME;

EID: 0031567974     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Notarangelo, L. D., M. Duse, A. G. Ugazio. 1992. Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev. 3:101.
2. Kroczek, R. A., D. Graf, D. Brugnoni, S. Giliani, U. Korthauer, A. G. Ugazio, G. Senger, H. W. Mages, A. Villa, and L. D. Notarangelo. 1994. Defective expression of CD40 ligand on T cells causes X-linked immunodeficiency with hyper IgM (XHIM). Immunol. Rev. 138:39.
3. Banatvala, N., J. Davies, M. Kanariou, M. Strobel, R. Levinsky, and G. Morgan. 1994. Hypogammaglobulinemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review. Arch. Dis. Child. 71:150.
4. Wiley, J. A., and A. G. Harmsen. 1995. CD40 ligand is required for resolution of Pneumocystis pneumonia in mice. J. Immunol. 155:3525.
5. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283.
6. Soong, L., J-C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley, N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263.
7. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275.
8. Filipovich, A. H., A. Mathur, D. Kamat, J. H. Kersey, and R. S. Shapiro. 1994. Lymphoproliferative disorders and other tumors complicating immunodeficiencies, Immunodeficiency 5:91.
9. Armitage, R. J., W. C. Fanslow, L. Strockbine, T. A. Sato, K. N. Clifford, B. M. Macduff, D. W. Anderson, S. D. Gimpel, T. Davis-Smith, C. R. Maliszewski, E. A. Clark, C. A. Smith, K. H. Grabstein, and M. K. Spriggs. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357:80.
10. Nishioka, Y., and P. E. Lipsky. 1994. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J. Immunol. 153:1027.
11. Paulie, S., A. Rosen, B. Ehlin-Hendriksson, S. Braesch-Andersen, E. Jakobson, H. Koho, and P. Perlmann. 1989. The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J. Immunol. 142:590.
12. Paulie, S., B. Ehlin-Hendriksson, H. Mellstedt, H. Koho, H. BenAissa, and P. Perlmann. 1985. A p50 surface antigen restricted to human bladder carcinomas and B lymphocytes. Cancer Immunol. Immunother. 20:23.
13. Fries, K. M., G. D. Sempowski, A. A. Gaspari, T. Blieden, R. J. Looney, and R. P. Phipps. 1995. CD40 expression by human tibroblasts. Clin. Immunol. Immunopathol. 77:42.
14. Hollenbaugh, D., N. Mischel-Petty, C. P. Edwards, J. C. Simon, R. W. Denfeld, P. A. Kiener, and A. Aruffo. 1995. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182:33.
15. Ruby, J., H. Bluethmann, M. Aguet, and I. A. Ramshaw. 1995. CD40 ligand has potent antiviral activity. Nat. Med. 1:437.
16. Adams, R. B., R. L. Guerrant, S. Zu, G. Fang, and J. K. Roche. 1994. Cryptosporidium parvum infection of intestinal epithelium: morphologic and functional studies in an in vitro model. J. Infect. Dis. 169:170.
17. Stamenkovic, I., E. A. Clark, and B. Seed. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8:1403.
18. Chiu, J. H., C. P. Hu, W. Y. Lui, S. C. Lo, and C. M. Chang. 1990. The formation of bile canaliculi in human hepatoma cell lines. Hepatology 11:834.
19. Zvibel, I., S. Brill, and L. M. Reid. 1995. Insulin-like growth factor regulation of gene expression in rat and human hepatomas. J. Cell. Physiol. 162:36.
20. Roskams, T., H. Mosage, E. Depla, M. Willems, V. Desmet, and P. Yap. 1995. Parathyroid hormone-related peptide is expressed and rapidly inducible in human liver cell cultures that have a bile duct phenotype. J. Hepatol. 23:160.
21. Niessen, R. W., B. A. Pfaffendorf, S. Sturk, R. J. Lamping, M. C. Schaap, C. E. Hack, and M. Peters. 1995. The influence of insulin, beta-estradiol, dexamethasone and thyroid hormone on the secretion of coagulant and anticoagulant proteins by HepG2 cells. Thromb. Haemost. 74:686.
22. Hollingdale, M. R., P. Leland, and A. L. Schwanz. 1983. In vitro cultivation of the exoerythrocytic stage of Plasmodium berghei in a hepatoma cell line. Am. J. Trop. Med. Hyg. 32:682.
23. Sinnis, P., P. Clavijo, D. Fenyo, B. T. Chait, C. Cerami, and V. Nussenzweig. 1994. Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J. Exp. Med. 180:297.
24. Cowart, R. E., J. Lashmet, M. E. McIntosh, and T. J. Adams. 1990. Adherence of a virulent strain of Listeria monocytogenes to the surface of a hepatocarcinoma cell line via lectin-substrate interaction. Arch. Microbiol. 153:282.
25. Macchi, P., A. Villa, D. Strina, M. G. Sacco, F. Morali, D. Brugnoni, S. Giliani, E. Mantuano, A. Fasth, B. Andersson, et al. 1995. Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry. Am. J. Hum. Genet. 56:898.
26. Valle, A., C. E. Zuber, T. Defrance, O. Djossou, M. De Rie, and J. Banchereau. 1989. Activation of human B lymphocytes through CD40 and interleukin 4. Eur. J. Immunol. 19:1463.
27. American Type Culture Collection. 1992. Catalogue of Cell Lines and Hybridomas, 7th Ed. American Type Culture Collection, Rockville, MD, p. 197.
28. Mazzei, G. J., M. D. Edgerton, C. Losberger, S. Lecoanet-Henchoz, P. Graber, A. Durandy, A. J. F. Gauchat, A. Bernard, B. Allet, and J. Y. Bonnefoy. 1995. Recombinant soluble trimeric CD40 ligand is biologically active. J. Biol. Chem. 270:7025.
29. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell dependent activation. J. Exp. Med. 177:1209.
30. Duke, R. 1994. Apoptosis. Current Protocols in Immunology, Vol. 3. John Wiley & Sons. New York. p. 17.
31. Farrington, M., L. S. Grosmaire, S. Nonoyama, S. H. Fischer, D. Hollenbaugh, J. A. Ledbetter, R. J. Noelle, A. Aruffo, and H. D. Ochs. 1994. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc. Natl. Acad. Sci. USA 91:1099.
32. Lederman, S., M. J. Yellin, G. Inghirami, J.J. Lee, D. M. Knowles, and L. Chess. 1992. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles: roles of T cell-B cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J. Immunol. 149:3817.
33. Arrowood, M. J., and C. R. Sterling. 1987. Isolation of Cryptosporidium oocysts sporozoites using discontinuous sucrose and isopycnic Percoll gradients. J. Parasitol. 73:314.
34. American Type Culture Collection. 1992. Catalogue of Cell Lines and Hybridomas, 7th Ed. American Type Culture Collection, Rockville, MD, no. VR 538.
35. Wentworth, B. B., and L. French. 1969. Plaque assay of Herpesvirus hominis on human embryonic fibroblasts. Proc. Soc. Exp. Biol. Med. 131:588.
36. Debray, D., D. Pariente, E. Urvoas, M. Hadchouel, and O. Bernard. 1994. Sclerosing cholangitis in children. J. Pediatr. 124:49.
37. Delaroque, E., C. Maslo, D. Salmon-Ceron, P. M. Girard, G. Salmot, and C. Leport. 1991. Sclerosing cholangitis in 14 AIDS patients: diagnosis and outcome. Int. Conference AIDS 7:253 (Abstr.).
38. Pang, K., C Mukonoweshuro, and G. G. Wong. 1994. Beta cells arise from glucose transporter type 2 (Glut2)-expressing epithelial cells of the developing rat pancreas. Proc. Natl. Acad. Sci. USA 91:9559.
39. Park, I. S., and M. Bendayan. 1993. Development of the endocrine cells in the rat pancreatic and bile duct system. Histochem. J. 25:807.
40. Kline, T. J., T. De las Morenas, M. O'Brien, B. F. Smith, and N. H. Afdhal. 1993. Squamous metaplasia of extrahepatic biliary system in an AIDS patient with cryptosporidia and cholangitis. Dig. Dis. Sci. 38:960.
41. Clark, E. A., and G. Shu. 1990. Association between IL-6 and CD40 signalling: IL-6 induces phosphorylation of CD40 receptors. J. Immunol. 145:1400.
42. Hess, S., and H. Engelmann. 1996. A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med. 183:159.
43. Wang, Z., J. G. Karras, R. G. Howard, and T. L. Rothstein. 1995. Induction of bcl-x by CD40 engagement rescues slg-induced apoptosis in murine B cells. J. Immunol. 155:3722.
44. Yang, S., M. C. Healey, C. Du, and J. Zhang. 1996. Complete development of Cryptosporidium parvum in bovine fallopian tube epithelial cells. Infect. Immun. 64:349.
45. Tizipori, S. 1988. Cryptosporidiosis in perspective. Adv. Parasital. 27:63.